EPAM Systems EPAM Options forfeited/expired (in dollars per share)

Options forfeited/expired (in dollars per share) at other companies

TRV

Trevi Therapeutics, Inc.TRVI

$0.00—

LivaNovaLIVN

$79.49+3.6%

TFS FinancialTFSL

$14.87-0.2%

Q2 HoldingsQTWO

$0.00—

Jazz PharmaceuticalsJAZZ

$167.80+12.6%

Baxter InternationalBAX

$54.86-15.9%

Other financials

Income statement

See full

Revenue$1.4B+7.6%

Gross profit$388.0M+11.0%

Operating income$116.8M+17.6%

Net income$82.5M+12.3%

EPS (diluted)$1.52+18.8%

Balance sheet

See full

Cash & equivalents$1.0B-11.5%

Total debt$287.9M+82.1%

Total equity$3.4B-5.8%

Total assets$4.7B-0.4%

Cash flow

See full

Operating cash flow-$36.4M-250%

CapEx$17.9M+91.4%

Free cash flow-$54.2M-466%

Valuation

See full

Market cap$4.02B-23.7%

Profitability

See full

Gross margin29%-1.2pp

Operating margin9.7%-1.3pp

Net margin7%-1.5pp

FCF margin9.8%+1.2pp

Returns & leverage

See full

Return on equity10.9%-0.6pp

Debt / equity0.1×0.0×

Current ratio2.7×-0.4×

Where this comes from

Reported directly by EPAM Systems in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice.

The official record: EPAM Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EPAM Systems's options forfeited/expired (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is EPAM Systems's options forfeited/expired (in dollars per share)?: EPAM Systems (EPAM) reported options forfeited/expired (in dollars per share) of $296.62 in Q1 2026.